Low‐dose aspirin (typically 75 mg/day) is recommended for all patients with JAK2 mutated ET to reduce arterial thrombosis risk, with a twice‐daily schedule generally reserved for those with problematic microvascular symptoms [75, 76, 77]. This evidence concerns the gene JAK2 and deep vein thrombosis.